3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
5
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Gallbladder Neoplasms
3
Cholangiocarcinoma
3
Urethral Neoplasms
2
Ureteral Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Brenner Tumor
2
Vulvar Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pinealoma
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Interventions
Ifosfamide
17
Methotrexate
16
Doxorubicin
14
Filgrastim
13
Etoposide
12
Cisplatin
12
Cyclophosphamide
10
Gemcitabine
9
Leucovorin
8
Sirolimus
6
Carboplatin
6
Topotecan
5
Irinotecan
5
Granulocyte Colony-Stimulating Factor
5
Temozolomide
4
Sorafenib
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Docetaxel
4
trimetrexate glucuronate
3
temsirolimus
3
dinutuximab
3
cixutumumab
3
apatinib
3
Vincristine
3
Specimen Handling
3
Oxaliplatin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Osteosarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts